FI923498A7 - Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi - Google Patents

Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI923498A7
FI923498A7 FI923498A FI923498A FI923498A7 FI 923498 A7 FI923498 A7 FI 923498A7 FI 923498 A FI923498 A FI 923498A FI 923498 A FI923498 A FI 923498A FI 923498 A7 FI923498 A7 FI 923498A7
Authority
FI
Finland
Prior art keywords
deoxymannosamine
derivatives
preparing
deoxymannosamine derivatives
Prior art date
Application number
FI923498A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923498A0 (fi
FI923498L (fi
Inventor
Nuccia Oneto
Cristina Geroni
Alberto Bargiotti
Nicola Mongelli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI923498A0 publication Critical patent/FI923498A0/fi
Publication of FI923498L publication Critical patent/FI923498L/fi
Publication of FI923498A7 publication Critical patent/FI923498A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI923498A 1991-08-06 1992-08-03 Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi FI923498A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (3)

Publication Number Publication Date
FI923498A0 FI923498A0 (fi) 1992-08-03
FI923498L FI923498L (fi) 1993-02-07
FI923498A7 true FI923498A7 (fi) 1993-02-07

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923498A FI923498A7 (fi) 1991-08-06 1992-08-03 Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi

Country Status (16)

Country Link
US (1) US5332756A (enExample)
EP (1) EP0527042A2 (enExample)
JP (1) JPH05208988A (enExample)
KR (1) KR930004325A (enExample)
AU (1) AU646173B2 (enExample)
CA (1) CA2075336A1 (enExample)
FI (1) FI923498A7 (enExample)
GB (1) GB9116896D0 (enExample)
HU (1) HU213208B (enExample)
IL (1) IL102500A (enExample)
MX (1) MX9204395A (enExample)
MY (1) MY108749A (enExample)
NZ (1) NZ243627A (enExample)
RU (1) RU2099333C1 (enExample)
TW (1) TW248564B (enExample)
ZA (1) ZA925871B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2266734C2 (ru) * 1999-05-13 2005-12-27 Фарма Мар, С.А. Композиции и применение ет743 для лечения злокачественных опухолей
US20080306011A1 (en) * 2004-05-26 2008-12-11 National University Corporation Kagawa University Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
KR20070060069A (ko) * 2004-06-23 2007-06-12 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 다당류 유도체 및 면역반응의 유도에서의 용도
WO2007106886A2 (en) * 2006-03-15 2007-09-20 Trustees Of Tufts College Fluorinated carbohydrates and their use in tumor visualization, tissue engineering, and cancer chemotherapy
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
AU2008272792B2 (en) 2007-07-03 2014-03-06 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
CA2692417C (en) * 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
IL102500A (en) 1996-01-19
KR930004325A (ko) 1993-03-22
IL102500A0 (en) 1993-01-14
HU213208B (en) 1997-03-28
AU2037492A (en) 1993-02-11
EP0527042A2 (en) 1993-02-10
RU2099333C1 (ru) 1997-12-20
CA2075336A1 (en) 1993-02-07
ZA925871B (en) 1993-04-28
EP0527042A3 (enExample) 1994-01-05
US5332756A (en) 1994-07-26
JPH05208988A (ja) 1993-08-20
FI923498A0 (fi) 1992-08-03
HU9202329D0 (en) 1992-10-28
FI923498L (fi) 1993-02-07
GB9116896D0 (en) 1991-09-18
AU646173B2 (en) 1994-02-10
HUT62593A (en) 1993-05-28
NZ243627A (en) 1994-04-27
MX9204395A (es) 1993-02-01
TW248564B (enExample) 1995-06-01
MY108749A (en) 1996-11-30

Similar Documents

Publication Publication Date Title
FI951595L (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI951591L (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI951592L (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI921021A7 (fi) Menetelmä trans-Pt(IV)-yhdisteiden valmistamiseksi
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI943643A7 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI940769A7 (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI952059A7 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI952585L (fi) Menetelmä bentsopyraaniyhdisteiden valmistamiseksi
FI921621L (fi) Sprutmetod foer braensle
NO920965D0 (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
FI923498A7 (fi) Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI940280L (fi) Menetelmä demetyyliepypodofyylilotoksiinin valmistamiseksi
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
FI944190A7 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
FI923360A7 (fi) Menetelmä dimetyyliasetoasetamidin valmistamiseksi
FI921103A7 (fi) Menetelmä oksamidin valmistamiseksi
FI893567A7 (fi) Menetelmä glykosfingolipidijohdannaisten valmistamiseksi
FI910366L (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
FI923799A7 (fi) Menetelmä metyyliasetaatin valmistamiseksi
FI913797A7 (fi) Menetelmä polyketonien valmistamiseksi
FI911633A7 (fi) Menetelmä alkaanisulfoanilidijohdosten valmistamiseksi
NO925007L (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
FI901293A7 (fi) Menetelmä triatsiinijohdannaisten valmistamiseksi
FI922174L (fi) Menetelmä -karboliinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed